Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tanreqing capsule for gut microbiota and intestinal barrier in colorectal cancer
ChiCTR2100052508Phase 4Not yet recruiting
- Sponsor
- Tianjin Union Medical Center
- Start
- Nov 2021
- Countries
- 1
01
Overview
Phase 4, randomised trial in colorectal cancer (CRC) comparing Tanreqing capsule with Placebo (2 arms). Primary endpoints: Gut microbiota composition, Lymphocyte subpopulations and 1 more. Planned start Nov 2021; status: not yet recruiting.
02
Drugs
tanreqing
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR2100052508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052508.